Search results
Dow Jones Today: Nvidia Rally Hands Nasdaq 5th Straight Winning Week
Investopedia· 3 days agoU.S. stocks rose on Friday as a Nvidia-fueled rally propelled the Nasdaq Composite to a record...
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 5 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoCAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Register Stunning Growth by 2032, Predicts DelveInsight | Key Companies - AUTOLUS THERAPEUTICS, CELLECTIS, WUGEN, SERVIER, ALLOGENE, PRECISION BIOSCIENCES PR Newswire LAS VEGAS, May 22,
Biogen says hello to HI-Bio, inking $1.15B buyout to expand in immunology
FierceBiotech· 5 days agoBiogen is placing a $1.15 billion bet on Chris Viehbacher’s diversification vision. The upfront payment has secured Biogen a deal to buy Human Immunology Biosciences (HI-Bio), a biotech that ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoEngitix Ltd (‘Engitix’), a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoAdlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will ...
